Patents by Inventor Pamela L. Zeitlin

Pamela L. Zeitlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction
    Patent number: 11963965
    Abstract: Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease, such as cystic fibrosis, in patients with residual function mutations.
    Type: Grant
    Filed: December 22, 2020
    Date of Patent: April 23, 2024
    Assignee: National Jewish Health
    Inventors: Preston E. Bratcher, Pamela L. Zeitlin
  • METHODS OF TREATING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) DYSFUNCTION
    Publication number: 20210196728
    Abstract: Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease, such as cystic fibrosis, in patients with residual function mutations.
    Type: Application
    Filed: December 22, 2020
    Publication date: July 1, 2021
    Inventors: Preston E. Bratcher, Pamela L. Zeitlin
  • Methods and compositions for treatment of cystic fibrosis
    Patent number: 8273700
    Abstract: The present invention relates to compounds and methods of inhibiting p97/valosin-containing protein and compounds and methods of inhibiting gp78, the compounds and methods being useful for the treatment of a disorder comprising a I?B/NF?B mediated chronic inflammatory response component, for example cystic fibrosis.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: September 25, 2012
    Assignee: The Johns Hopkins University
    Inventors: Neeraj Vij, Pamela L. Zeitlin
  • Methods and Compositions for Treatment of Cystic Fibrosis
    Publication number: 20100222408
    Abstract: The present invention relates to compounds and methods of inhibiting p97/valosin-containing protein and compounds and methods of inhibiting gp78, the compounds and methods being useful for the treatment of a disorder comprising a I?B/NF?B mediated chronic inflammatory response component, for example cystic fibrosis.
    Type: Application
    Filed: September 29, 2006
    Publication date: September 2, 2010
    Applicant: The Johns Hopkins University
    Inventors: Pamela L. Zeitlin, Neeraj Vij
  • Modulation of protein expression using carbocyclic aryl alkenoic acid derivatives
    Patent number: 7557144
    Abstract: The present invention generally relates to diseases or conditions modulated by undesired protein expression. In one aspect, the methods provide for administration to a mammal, particularly a human, of a therapeutically effective amount of a carbocyclic aryl compound capable of modulating that undesired protein expression. Assays for detecting compounds having desired therapeutic capacity are also provided.
    Type: Grant
    Filed: March 11, 2000
    Date of Patent: July 7, 2009
    Assignee: The Johns Hopkins University
    Inventors: Pamela L. Zeitlin, Saul Brusilow